News
-
-
-
-
PRESS RELEASE
Significant Positive Results with Jaguar Health's Crofelemer for Chronic Refractory Diarrhea in IBS-D, Presented at American College of Gastroenterology Annual Meeting
Napo Pharmaceuticals announces abstracts for two investigator-initiated studies on crofelemer for chronic refractory diarrhea patients, presented at ACG 2024. Jaguar CEO Lisa Conte comments on crofelemer's clinical robustness and impact on IBS-D patients -
PRESS RELEASE
Klondike Gold Discovers 300-meter Southeastern Extension to Stander Zone in Drilling Including 21.50 g/t Au over 4.0 meters (Including 76.07 g/t Au Over 1.0 Meter and 9.50 g/t Au Over 1.0 Meter) and 4.84 g/t Au over 9.0 Meters (Including 35.44 g/t Au over
Klondike Gold Corp. reports high-grade gold results from Stander Zone southeastern extension drill holes in Klondike District Property, Yukon, Canada -
-
PRESS RELEASE
Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research raises price target for Pharming Group NV after Q3/24 results. CEO not seeking reappointment unrelated to business. Market undervaluing APDS drug sales potential. Expect significant revenue growth -
-
REGULATED PRESS RELEASE
Acquisition de BIO Habitat
Trigano obtient l'autorisation d'acquérir 100% de BIO Habitat et sa filiale BIO Habitat Italia, renforçant sa position dans la construction de mobil-homes. Une opération stratégique pour consolider son leadership dans l'industrie des Véhicules de Loisirs en Europe -
